I am having a hard time with the whole vaccine dev
Post# of 36536
(Total Views: 292)
Posted On: 09/16/2020 11:15:42 AM
I am having a hard time with the whole vaccine development process. So I had to open up the original China timeline (8k - dated 3/2/20 if anyone wants to look)...
Task 3: Testing the peptides against CV-19. We did receive an update months ago that this was in process (date???). This was shown as a 3 week process.
Milestone out of this was "Vaccine for the COVID-19 identified". Did this happen???
Task 4: Make small-scale "GMP-like" grade peptide - 2 weeks
Task 5: Test 5 peptides - pre-clinical (animal testing) - about 1 week
Task 6: Test 5 peptides in Phase I human trials - we have been told multiple times this will not be required due to the safety profile of peptide vaccines.
Milestone: Identify 3 safe Ii-key COVID-19 peptide vaccines
So this entire portion of the process is shown as 6 total weeks, if the human trials are not required. What has happened? What hasn't happened?
Clearly we are not there yet, and there are 3 possibilities.
1) It was a failure. The peptides did not work. If that is the case, did they start over with a new batch of peptides? If that is the end of the road, we should be notified.
2) They haven't completed the process yet. If this is the case, why was the original timeline given so short, and what led to the extended timeline? Where are we now, and what is the new timeline?
3) They were successful in developing a vaccine. If there was success in reaching this stage, the entire world should know about it.
And THAT is why the cancellation of the NGIO CC was so irritating. We have had no chance to find out where this process is.
I think Joe needs to re-schedule the call for next week and be prepared to speak to the status of this process. No one owns this process but Generex. So it is Joe's decision whether to give an update or not, regardless of what our "partners" think.
In fact, if there is any level of success, put it out there. If our "partners" haven't inked a deal by then, let them have more competition.
If Joe sits in silence on this much longer, and not one "partner" chooses to ink a deal, then all the market can do is assume (rightly so, IMO) that there is no success.
Time to prove the case, Joe. Give us all the success you've had. Generate some interest.
Let me guess. We can't have that call now that the S1s have been submitted. If that is the case, there should have been an update/call before that happened.
And what is the threshold for what can/can't be said? Could a peptide success be made public? If there is a successful vaccine during the S1 review period, you can bet your butt THAT will be made public...
Task 3: Testing the peptides against CV-19. We did receive an update months ago that this was in process (date???). This was shown as a 3 week process.
Milestone out of this was "Vaccine for the COVID-19 identified". Did this happen???
Task 4: Make small-scale "GMP-like" grade peptide - 2 weeks
Task 5: Test 5 peptides - pre-clinical (animal testing) - about 1 week
Task 6: Test 5 peptides in Phase I human trials - we have been told multiple times this will not be required due to the safety profile of peptide vaccines.
Milestone: Identify 3 safe Ii-key COVID-19 peptide vaccines
So this entire portion of the process is shown as 6 total weeks, if the human trials are not required. What has happened? What hasn't happened?
Clearly we are not there yet, and there are 3 possibilities.
1) It was a failure. The peptides did not work. If that is the case, did they start over with a new batch of peptides? If that is the end of the road, we should be notified.
2) They haven't completed the process yet. If this is the case, why was the original timeline given so short, and what led to the extended timeline? Where are we now, and what is the new timeline?
3) They were successful in developing a vaccine. If there was success in reaching this stage, the entire world should know about it.
And THAT is why the cancellation of the NGIO CC was so irritating. We have had no chance to find out where this process is.
I think Joe needs to re-schedule the call for next week and be prepared to speak to the status of this process. No one owns this process but Generex. So it is Joe's decision whether to give an update or not, regardless of what our "partners" think.
In fact, if there is any level of success, put it out there. If our "partners" haven't inked a deal by then, let them have more competition.
If Joe sits in silence on this much longer, and not one "partner" chooses to ink a deal, then all the market can do is assume (rightly so, IMO) that there is no success.
Time to prove the case, Joe. Give us all the success you've had. Generate some interest.
Let me guess. We can't have that call now that the S1s have been submitted. If that is the case, there should have been an update/call before that happened.
And what is the threshold for what can/can't be said? Could a peptide success be made public? If there is a successful vaccine during the S1 review period, you can bet your butt THAT will be made public...
(5)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼